⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23457288 | 0.78 | — | — | |
| SCHEMBL7679714 | 0.76 | — | — | |
| SCHEMBL14048787 | 0.74 | — | — | |
| SCHEMBL4427692 | 0.74 | SMN1; SMN2 (0.40) | — | |
| SCHEMBL26916381 | 0.73 | NR3C2 (0.37) | — | |
| SCHEMBL1703146 | 0.71 | — | — | |
| SCHEMBL18145746 | 0.71 | ALDH1A1 (0.39) | — | |
| SCHEMBL18529372 | 0.71 | — | — | |
| SCHEMBL858918 | 0.71 | — | — | |
| SCHEMBL3005642 | 0.70 | KMT2A (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 447 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12221439-B2 | Tetrahydropyridopyrimidine derivatives as AhR modulators | JAGUAHR THERAPEUTICS PTE LTD (SG) | 2025-02-11 | — | — | US | claimed |
| CN-106928143-B | Preparation method of 2- (4-bromo-1-methyl-1H-pyrazol-5-yl) ethylamine | 北京六合宁远科技有限公司 | 2020-05-01 | — | — | CN | claimed |
| CN-106928143-A | Preparation method of 2- (4-bromo-1-methyl-1H-pyrazol-5-yl) ethylamine | 北京六合宁远科技有限公司 | 2017-07-07 | — | — | CN | claimed |
| EP-1819693-B1 | ANTITHROMBOTIC DIAMIDES | LILLY CO ELI (US) | 2009-08-26 | — | — | EP | claimed |
| US-20260070924-A1 | INDAZOLE MACROCYCLES AND THEIR USE | BLOSSOMHILL THERAPEUTICS INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-20260001846-A1 | SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS | SERVIER LAB (FR) | 2026-01-01 | — | — | US | disclosed |
| US-20250368625-A1 | PIPERAZINES | Grünenthal GmbH (DE) | 2025-12-04 | — | — | US | disclosed |
| US-20250353864-A1 | INDAZOLE CONTAINING MACROCYCLES AND THEIR USE | BLOSSOMHILL THERAPEUTICS INC (US) | 2025-11-20 | — | — | US | disclosed |
| US-20250326732-A1 | CHROMEN-2-ONE MODULATORS OF POLRMT | PRETZEL THERAPEUTICS, INC. (US) | 2025-10-23 | — | — | US | disclosed |
| US-12377083-B2 | Lysophosphatidic acid receptor antagonist and preparation method therefor | WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD. (CN) | 2025-08-05 | — | — | US | disclosed |
| US-20250243217-A1 | COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2025-07-31 | — | — | US | disclosed |
| US-12358879-B2 | Heterocyclic compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2025-07-15 | — | — | US | disclosed |
| EP-0796858-A1 | Triazole antifungal agents | Pfizer Limited (GB) | 1997-09-24 | — | — | EP | disclosed |
| CN-1016783-B | PROMOTING AGENT OF ACTIVITY OF SOME ANTITUMOR AGENT AGAINST VARIOUS KINDS OF TUMOR CELL | KYOLIN MEDICINE CO LTD (JP) | 1992-05-27 | — | — | CN | disclosed |
| EP-0268800-B1 | PHENOXYACETIC ACID DERIVATIVES AND PROCESSES FOR PREPARING THE SAME | Tanabe Seiyaku Co., Ltd. (JP) | 1992-02-05 | — | — | EP | disclosed |
| CN-1014787-B | Process for producing phenoxyacetic acid derivatives | TANABE SEIYAKU CO (JP) | 1991-11-20 | — | — | CN | disclosed |
| CN-87101183-A | Promotor of antitumor reagent activity and preparation method thereof | — | 1988-06-08 | — | — | CN | disclosed |
| CN-87106895-A | Phenoxyacetic acid derivatives and process for producing the same | — | 1988-04-20 | — | — | CN | disclosed |
| US-4390693-A | BACTERICIDE | MERCK & CO., INC. (US) | 1983-06-28 | — | — | US | disclosed |
| US-4255423-A | BACTERICIDES | MERCK & CO., INC. (US) | 1981-03-10 | — | — | US | disclosed |